RYLOJAX

Serial Number 98673968
688

Registration Progress

Application Filed
Jul 30, 2024
Under Examination
Mar 18, 2025
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Sep 18, 2025 46 days

Trademark Image

RYLOJAX

Basic Information

Serial Number
98673968
Filing Date
July 30, 2024
Published for Opposition
January 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 18, 2025
Application
Pending
Classes
005 016 044

Rights Holder

Incyte Holdings Corporation

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

Incyte Holdings Corporation

Original Applicant
03
Wilmington, DE

Incyte Holdings Corporation

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
46 days remaining
NOA E-Mailed - SOU Required
Due Date
September 18, 2025
Extension Available
Until March 18, 2026

Application History

8 events
Date Code Type Description Documents
Mar 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 30, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 30, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders

Classification

International Classes
005 016 044